statistiche ricercatore

Continente	#
AS - Asia	485
NA - Nord America	393
EU - Europa	314
SA - Sud America	55
Continente sconosciuto - Info sul continente non disponibili	36
AF - Africa	19
OC - Oceania	2
Totale	1.304

Nazione	#
US - Stati Uniti d'America	364
SG - Singapore	169
CN - Cina	157
IT - Italia	114
HK - Hong Kong	65
BR - Brasile	45
NL - Olanda	34
RU - Federazione Russa	28
FR - Francia	27
FI - Finlandia	22
IN - India	21
VN - Vietnam	20
DE - Germania	18
GB - Regno Unito	18
BD - Bangladesh	15
SE - Svezia	15
CA - Canada	14
CI - Costa d'Avorio	14
MX - Messico	8
AT - Austria	7
ES - Italia	7
ID - Indonesia	7
IQ - Iraq	7
JP - Giappone	6
PL - Polonia	6
TR - Turchia	5
BE - Belgio	4
ZA - Sudafrica	4
IE - Irlanda	3
PT - Portogallo	3
SA - Arabia Saudita	3
AU - Australia	2
EC - Ecuador	2
NI - Nicaragua	2
TW - Taiwan	2
UA - Ucraina	2
VE - Venezuela	2
AE - Emirati Arabi Uniti	1
AR - Argentina	1
AZ - Azerbaigian	1
CH - Svizzera	1
CL - Cile	1
CO - Colombia	1
CR - Costa Rica	1
CU - Cuba	1
CZ - Repubblica Ceca	1
DK - Danimarca	1
GR - Grecia	1
JM - Giamaica	1
LA - Repubblica Popolare Democratica del Laos	1
LK - Sri Lanka	1
LT - Lituania	1
LV - Lettonia	1
MA - Marocco	1
MQ - Martinica	1
MY - Malesia	1
PE - Perù	1
PH - Filippine	1
PK - Pakistan	1
PY - Paraguay	1
TH - Thailandia	1
TT - Trinidad e Tobago	1
UY - Uruguay	1
Totale	1.268

Nome	#
Emergency Department and Out-of-Hospital Emergency System (112-AREU 118) integrated response to Coronavirus Disease 2019 in a Northern Italy centre	254
Long-term dynamics of natural killer cells in response to SARS-CoV-2 vaccination: Persistently enhanced activity postvaccination	210
High‐throughput peptide array analysis and computational techniques for serological profiling of flavivirus infections: Implications for diagnostics and vaccine development	159
Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6-8 months after the infection	133
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy	124
Immunity to SARS-CoV-2 up to 15 months after infection	124
Severe acute respiratory syndrome coronavirus 2 RNA contamination of inanimate surfaces and virus viability in a health care emergency unit	123
Performance of VivaDiag COVID‐19 IgM/IgG Rapid Test is inadequate for diagnosis of COVID‐19 in acute patients referring to emergency room department	96
Serum and breastmilk SARS-CoV-2 specific antibodies following BNT162b2 vaccine: prolonged protection from SARS-CoV-2 in newborns and older children	81
Totale	1.304

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	31	0	1	0	0	3	0	1	1	3	3	2	17
2022/2023	33	5	4	1	2	4	6	1	3	1	0	5	1
2023/2024	37	0	0	3	0	4	2	0	0	2	7	7	12
2024/2025	437	32	27	17	35	29	19	21	42	27	54	53	81
2025/2026	693	80	70	80	90	55	36	88	20	37	58	39	40
2026/2027	58	18	40	0	0	0	0	0	0	0	0	0	0
Totale													1.304

IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca